Best ED Telehealth Providers in 2026 — Ranked & Reviewed
Most online erectile dysfunction platforms sell compounded multi-ingredient products — sildenafil, tadalafil, or a combination in a dissolvable troche or chewable tablet — that are not FDA-approved single-agent therapies. Only branded Viagra (sildenafil), Cialis (tadalafil), Stendra (avanafil), Levitra (vardenafil), and their FDA-approved generics have been through Phase 3 trials and FDA review. Neither path is wrong — the difference is evidence and price. We ranked every ED telehealth provider in our directory on price transparency, drug formulary, pharmacy-partner disclosure, state availability, and honest FDA-status framing, and note where care overlaps with GLP-1 weight-loss treatment, since weight loss itself improves erectile function in many men.
Lowest verified price: $25/mo4 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
4 ed telehealth providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
low-cost generic sildenafil and tadalafil ED telehealth
From /mo$25CoverageCheck intakeMedicationsSildenafilTadalafil - Transparent Pricing
compounded multi-ingredient ED with named pharmacy and clinical network
From /mo$99Coverage49 statesMedicationsSildenafilTadalafilApomorphineVardenafil named-clinician TRT, ED and thyroid care with an in-house CLIA lab
From /mo$65Coverage41 statesMedicationsSildenafilTadalafil- Best Budget
multi-vertical men's-health platform spanning ED, TRT, hair and sleep
From /moFreeCoverageCheck intakeMedicationsSildenafilTadalafilApomorphine
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick low-cost generic sildenafil and tadalafil ED telehealth | $25 | SildenafilTadalafil | Check intake | Visit → | |
Transparent Pricing compounded multi-ingredient ED with named pharmacy and clinical network | $99 | SildenafilTadalafilApomorphineVardenafil | 49 states | Visit → | |
 named-clinician TRT, ED and thyroid care with an in-house CLIA lab | $65 | SildenafilTadalafil | 41 states | Visit → | |
Best Budget multi-vertical men's-health platform spanning ED, TRT, hair and sleep | Free | SildenafilTadalafilApomorphine | Check intake | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
MyDrHank
Verified partnerBest for: low-cost generic sildenafil and tadalafil ED telehealth
MyDrHank (Dr. Hank, LLC) is a direct-to-consumer telehealth platform listed here for its erectile-dysfunction line — generic sildenafil, generic and daily tadalafil, and MDH Drive, a rapid-dissolve sildenafil-plus-tadalafil tablet. U.S.-licensed providers review every case online, and it names three pharmacy partners. Itemized monthly, 3-month, and 6-month plans run from $25/mo for generic sildenafil, with no commitment and free shipping.
Score Breakdown
Pros
- ✓Operating legal entity named: Dr. Hank, LLC
- ✓Three named pharmacy partners disclosed (Dunklau Pharmacy Holdings, InnovaScript, PCM Venture I Pharmacy)
- ✓Itemized pricing on every product with clear monthly / 3-month / 6-month tiers
- ✓Generic sildenafil at $25/mo on the 6-month plan is competitive with the lowest-cost ED platforms
- ✓Compounded sildenafil+tadalafil rapid-dissolve tablet at $45–$59/mo undercuts comparable combo pricing
- ✓Daily tadalafil at $35/mo offers a low-dose always-ready option below retail Cialis Daily
- ✓Free shipping and discreet packaging on every plan, with 'cancel anytime' and no hidden fees
- ✓Case reviewed by a licensed US physician within 24 hours of intake
Cons
- ✗ED-focused — its broader GLP-1, hair, and peptide verticals aren't the basis for this listing
- ✗The combo rapid-dissolve tablet is compounded, not FDA-approved, and unstudied at this dose ratio
- ✗Specific mg dosing not disclosed before purchase — prevents apples-to-apples price comparison
- ✗States served not listed publicly
- ✗No money-back guarantee or refund window disclosed
- ✗No LegitScript, PCAB, or BBB trust signals — thinner than peers like BraveRx or Male Excel
- ✗About/Pricing/FAQ URLs return 404 — single-page app hurts crawlability
- ✗'10,000+ patients treated' claim is unaudited with no third-party reviews
BraveRx
Verified partnerBest for: compounded multi-ingredient ED with named pharmacy and clinical network
BraveRx is a Miami-based DTC telehealth platform for erectile dysfunction — not a GLP-1 or weight-loss provider — selling compounded multi-ingredient sublingual tablets and capsules that combine PDE5 inhibitors with apomorphine and other actives. It names both its compounding pharmacy (Chemistry Rx) and clinical network (Beluga Health), and displays LegitScript, HIPAA, and PCAB badges. Products run $99–$179, available in all states except North Dakota.
Score Breakdown
Pros
- ✓Operating entity disclosed (Brave Labs LLC operating as BraveRx) with a Miami HQ address
- ✓Names its compounding pharmacy partner (Chemistry Rx, Folcroft PA)
- ✓Names its clinical network (Beluga Health P.A.)
- ✓Itemized USD pricing on every product page with dose-strength breakdowns
- ✓LegitScript, HIPAA, and PCAB accreditation badges in the footer
- ✓BBB A+ rating
- ✓Available in all 50 states except North Dakota — wide coverage for a compounded-ED provider
- ✓Product price ($99–$179) includes consult, ongoing support, and free shipping
Cons
- ✗ED-only — not a GLP-1 or weight-loss provider; listed mainly for affiliate transparency
- ✗All flagship products are compounded multi-ingredient formulations — not FDA-approved and not studied in randomized trials
- ✗Some products contain apomorphine, which is FDA-approved for Parkinson's, not ED, and has limited off-label safety data
- ✗One product combines icariin (a botanical supplement) with a compounded PDE5 inhibitor — unusual and not RCT-supported
- ✗Some products use vardenafil, whose branded forms were discontinued in the US; compounded supply depends on undetailed sourcing
- ✗Support hours are weekdays 9am–6pm ET only — no 24/7 medical support
- ✗Refund policy is discretionary, with no documented money-back window
- ✗Shopify-hosted storefront — clinical encounters happen on the separate Beluga Health platform
Male Excel
Best for: named-clinician TRT, ED and thyroid care with an in-house CLIA lab
Male Excel (Male Excel Inc. dba Excel Medical) is a Charlotte, NC men's-health telehealth practice offering testosterone replacement therapy, ED treatment, and bioidentical thyroid care — not GLP-1 or weight loss. It stands out for an in-house CLIA-certified lab, named clinical leadership, and 30+ listed prescribers. TRT starts at $120/month plus a required $99/month membership and one-time $99 consult; available in 41 states.
Score Breakdown
Pros
- ✓Operating entity disclosed: Male Excel Inc. dba Excel Medical, Charlotte NC, governed by North Carolina law
- ✓Named clinical leadership: Peter Fotinos MD (CMO) and Lorna Brudie DO (Medical Director) with verifiable credentials
- ✓30+ individual prescribers named on the site — high transparency for TRT telehealth
- ✓In-house CLIA-certified lab with initial and 6-month follow-up labs in the $99/mo membership
- ✓Itemized starting prices published with supply duration and dose strengths
- ✓LegitScript certification displayed in the footer
- ✓Operating since 2019 with sister brand FemExcel
- ✓Wide coverage (41 states) with a clear excluded-state list
Cons
- ✗Outside the GLP-1/weight-loss scope — TRT, ED, thyroid, and peptide therapy only, no semaglutide or tirzepatide
- ✗Binding Terms state all sales are final and non-refundable, overriding the marketing's 90-day refund claim
- ✗True cost stacks membership + consult + medication — roughly $219 first month and $219/mo recurring, above the $120 headline
- ✗Triclozene (clomiphene) is off-label for male hypogonadism — legal but not FDA-evaluated for that use
- ✗Pricing page doesn't say whether testosterone injection and cream are FDA-approved or compounded — confirm at intake
- ✗Pharmacy partner not named, making licensure verification difficult before purchase
- ✗Thyroid pricing not separately disclosed — only 'included when clinically appropriate'
- ✗'100,000+ patients' and 'nearly two decades' marketing claims are unaudited and conflict with the 2019 launch
Rugiet Health
Best for: multi-vertical men's-health platform spanning ED, TRT, hair and sleep
Rugiet Health is an Austin, TX men's-health telehealth platform (MSB Holdings Inc.) spanning erectile dysfunction, testosterone, hair, and sleep — not a GLP-1 weight-loss provider. Its flagship Rugiet Ready is a compounded sublingual sildenafil + tadalafil + apomorphine formulation, backed by two named pharmacy partners plus LegitScript and HIPAA badges. Pricing starts around $7.29/dose; its 'Weigh In' product is a compounded oral combination, not a GLP-1.
Score Breakdown
Pros
- ✓Operating entity disclosed: MSB Holdings Inc., Austin TX, with full address and Texas governing-law clause
- ✓Two named compounding pharmacy partners disclosed: The Pharmacy HUB LLC (Miami Gardens FL) and Triad Rx (Daphne AL)
- ✓LegitScript Certified and HIPAA Compliant badges displayed
- ✓Trustpilot 4.3 stars / 1,208 reviews surfaced on the product page
- ✓Multi-vertical platform (ED, TRT, hair, sleep, oral weight loss) consolidates men's-health needs
- ✓Cancellation terms disclosed (72 hours before billing; service runs through the cycle)
- ✓Customer-care phone and email with 6-day-a-week hours
Cons
- ✗ED-focused, not GLP-1 weight loss — outside the core weight-loss use case
- ✗Flagship Rugiet Ready is a compounded sildenafil + tadalafil + apomorphine combo not studied in published trials
- ✗Apomorphine for ED is off-label with limited modern safety data
- ✗Exact mg dose strengths not shown before the intake questionnaire
- ✗Weight-loss product 'Weigh In' is compounded bupropion + naltrexone + metformin — not a GLP-1 and inferior for weight loss
- ✗State availability not listed anywhere on the site
- ✗Medical group / clinical network not named; medical director not identified
- ✗Restrictive refunds — only before the medication is ordered; bundles get prorated refunds only
How to choose an ED telehealth provider
Most online ED platforms sell compounded multi-ingredient products (sildenafil/tadalafil troches or chewables), not FDA-approved single-agent medications. Neither option is wrong — but the platform should be honest about which one you're getting.
What to look for
- FDA-approved single-agent vs. compounded. Generic sildenafil and tadalafil are FDA-approved and studied in Phase 3 trials at specific doses. Compounded multi-ingredient troches or chewables use the same active molecules but haven't been trial-tested as a combination — a reasonable option, just a different risk/evidence profile.
- Named, licensed compounding pharmacy. For compounded products, the platform should name its fulfillment pharmacy (and it should be traceable via its state Board of Pharmacy). An unnamed 'partner pharmacy network' is a transparency gap.
- Cardiovascular screening before you start. New-onset ED with no obvious cause can be an early cardiovascular marker, and PDE5 inhibitors are contraindicated with nitrate use. A legitimate intake screens for cardiac history and current medications — not just an order form.
Red flags to avoid
- No named pharmacy or licensing disclosed. A legitimate compounded-ED provider names its 503A/503B pharmacy partner. If the site only says 'our pharmacy network' with no specifics, you can't verify what you're taking.
- Implying compounded = FDA-approved. Compounded sildenafil/tadalafil combinations are not FDA-approved and have not been through the pivotal trials at the doses sold. A platform that markets its compounded product as equivalent to Viagra or Cialis, rather than disclosing the difference, is misleading you.
- No nitrate or cardiac-history screening. PDE5 inhibitors are dangerous combined with nitrates and can mask a cardiac workup that new-onset ED may warrant. An intake that skips this screening is a safety gap, not a convenience.
- Teaser pricing that hides the real monthly cost. A low first-tier price that jumps sharply at a 'standard' or 'high-frequency' tier can double the real monthly total. Confirm the ongoing price before you pay.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.